We recently reported on the AGA Medical (NASDAQ: AGAM) – developer of interventional devices for the minimally invasive treatment of structural heart defects and peripheral vascular disorders – public filing intentions and can now follow-up with their initial public offering debut details and as well check in with AGA’s Bio IPO class of 2009 brethren. [...]